In Vitro and In Vivo Cardioprotective Effects of Curcumin against Doxorubicin-Induced Cardiotoxicity: A Systematic Review

Abstract

Objective. This study aimed to review the potential chemoprotective effects of curcumin against the doxorubicin-induced cardiotoxicity. Methods. According to the PRISMA guideline, a comprehensive systematic search was performed in different electronic databases (Web of Science, PubMed, and Scopus) up to July 2021. One hundred and sixty-four studies were screened in accordance with a predefined set of inclusion and exclusion criteria. Eighteen eligible articles were finally included in the current systematic review. Results. According to the in vitro and in vivo findings, it was found that doxorubicin administration leads to decreased cell survival, increased mortality, decreased bodyweight, heart weight, and heart to the bodyweight ratio compared to the control groups. However, curcumin cotreatment demonstrated an opposite pattern in comparison with the doxorubicin-treated groups alone. Other findings showed that doxorubicin significantly induces biochemical changes in the cardiac cells/tissue. Furthermore, the histological changes on the cardiac tissue were observed following doxorubicin treatment. Nevertheless, for most of the cases, these biochemical and histological changes mediated by doxorubicin were reversed near to control groups following curcumin coadministration. Conclusion. It can be mentioned that coadministration of curcumin alleviates the doxorubicin-induced cardiotoxicity. Curcumin exerts these cardioprotective effects through different mechanisms of antioxidant, antiapoptosis, and anti-inflammatory. Since the finding presented in this systematic review are based on in vitro and in vivo studies, suggesting the use of curcumin in cancer patients as a cardioprotector agent against cardiotoxicity mediated by doxorubicin requires further clinical studies.

A systematic review of the therapeutic effects of resveratrol in combination with 5-fluorouracil during colorectal cancer treatment: with a special focus on the oxidant, apoptotic, and anti-inflammatory activities

“…The inflammatory process is a biological phenomenon which occurs in response to tissue damage induced from several harmful stimuli such as chemotherapy, radiation, microbial pathogen infection, and/or wounding [ 116 – 121 ]. Among the characteristics of inflammation are: elevation in leukocyte migration to injured area, upregulation of pro-inflammatory cytokines, and leukocyte chemotaxis [ 122 , 123 ].…”

Curcumin Sensitizes 4T1 Murine Breast Cancer Cells to Cisplatin Through PAR4 Secretion

“…However, in cells cultured with 20% mouse serum, an increase in cell proliferation of approximately 50% within 24 h was seen in both 4T1 cells and other breast cancer cell lines (data not shown). The trace amounts of curcumin present in serum may have induced the increase in cell proliferation, given the radio-and chemo-protective capacity of curcumin, and it may have promoted the expression of proliferation-inducing molecules (37,38). Gardane et al reported that low concentrations of curcumin (10 μg/ml and 20 μg/ml) stimulated the proliferation of KG-1a cells, whereas high concentrations (30 μg/ml to 100 μg/ml) induced an inhibitory effect (39).…”

The Self-Administered Use of Complementary and Alternative Medicine (CAM) Supplements and Antioxidants in Cancer Therapy and the Critical Role of Nrf-2—A Systematic Review

“…Two recent systematic reviews collected data from in vitro and in vivo studies with curcumin (CC) co-administered as a cardioprotective agent [ 155 , 156 ]. Curcumin is a phytochemical that is obtained from the rhizomes of Curcuma longa L. and it acts as an antioxidant with anti-apoptotic and anti-inflammatory effects on healthy cells.…”